Covered recipient · General Payments record
JEFFREY BERNSTEIN
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2019–2024
$853.58
- Reported across 47 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $518.72 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $211.44 | 12 |
| Celgene Corporation | $82.63 | 4 |
| Gilead Sciences, Inc. | $74.94 | 4 |
| Janssen Biotech, Inc. | $51.68 | 2 |
| Madrigal Pharmaceuticals | $35.94 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $29.84 | 1 |
| Phathom Pharmaceuticals, Inc. | $18.76 | 1 |
| CapsoVision, Inc. | $13.49 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2019202020212023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.49 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103315338 | CMS |
| ABBVIE INC. | $9.10 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103315340 | CMS |
| ABBVIE INC. | $16.86 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103315342 | CMS |
| ABBVIE INC. | $15.27 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103315344 | CMS |
| ABBVIE INC. | $16.54 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103315346 | CMS |
| ABBVIE INC. | $16.32 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103315348 | CMS |
| ABBVIE INC. | $22.87 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103315350 | CMS |
| ABBVIE INC. | $20.28 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103315352 | CMS |
| ABBVIE INC. | $16.59 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103315354 | CMS |
| ABBVIE INC. | $22.40 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103315356 | CMS |
| ABBVIE INC. | $17.73 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103315358 | CMS |
| ABBVIE INC. | $18.99 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103315360 | CMS |
| CapsoVision, Inc. | $13.49 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154308854 | CMS |
| Celgene Corporation | $20.96 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101077046 | CMS |
| Celgene Corporation | $19.65 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101077048 | CMS |
| Celgene Corporation | $20.84 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101077052 | CMS |
| Celgene Corporation | $21.18 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101077054 | CMS |
| Gilead Sciences, Inc. | $15.15 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133776371 | CMS |
| Gilead Sciences, Inc. | $16.23 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133776373 | CMS |
| Gilead Sciences, Inc. | $20.81 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133776375 | CMS |
| Gilead Sciences, Inc. | $22.75 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133776377 | CMS |
| Janssen Biotech, Inc. | $27.04 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078725387 | CMS |
| Janssen Biotech, Inc. | $24.64 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078725434 | CMS |
| Madrigal Pharmaceuticals | $35.94 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144161637 | CMS |
| Phathom Pharmaceuticals, Inc. | $18.76 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151040084 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $29.84 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137486867 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.